RSLS — ReShape Lifesciences Inc

Stock analysis, AI verdict, fundamentals & technical signals

Rating: NEUTRAL

Price: $3.92 Analyst target: $1.00 Upside: -74.49%

See the full interactive analysis & chart →

Informational only — not investment advice.